Orally disintegrating tablets containing famotidine nanoparticles provide high intestinal absorbability via the energy-dependent endocytosis pathway
暂无分享,去创建一个
F. Ogata | N. Kawasaki | Y. Nakazawa | N. Nagai | H. Otake | Saori Deguchi | Mayumi Nagata | Reita Kadowaki | H. Sasaki
[1] F. Ogata,et al. Oral Formulation Based on Irbesartan Nanocrystals Improve Drug Solubility, Absorbability, and Efficacy , 2022, Pharmaceutics.
[2] F. Ogata,et al. Nanocrystalline Suspensions of Irbesartan Enhance Oral Bioavailability by Improving Drug Solubility and Leading Endocytosis Uptake into the Intestine , 2021, Pharmaceutics.
[3] F. Ogata,et al. Fixed-Combination Eye Drops Based on Fluorometholone Nanoparticles and Bromfenac/Levofloxacin Solution Improve Drug Corneal Penetration , 2021, International journal of nanomedicine.
[4] F. Ogata,et al. Oral Administration System Based on Meloxicam Nanocrystals: Decreased Dose Due to High Bioavailability Attenuates Risk of Gastrointestinal Side Effects , 2020, Pharmaceutics.
[5] J. Huwyler,et al. Mechanisms of increased bioavailability through amorphous solid dispersions: a review , 2019, Drug delivery.
[6] Yoshihiro Oaku,et al. Drug Delivery System Based On Minoxidil Nanoparticles Promotes Hair Growth In C57BL/6 Mice , 2019, International journal of nanomedicine.
[7] F. Ogata,et al. Energy-dependent endocytosis is responsible for drug transcorneal penetration following the instillation of ophthalmic formulations containing indomethacin nanoparticles , 2019, International journal of nanomedicine.
[8] H. Byrne,et al. Cold Atmospheric Plasma Induces ATP-Dependent Endocytosis of Nanoparticles and Synergistic U373MG Cancer Cell Death , 2018, Scientific Reports.
[9] Bazigha K. Abdul Rasool,et al. Optimized Mucoadhesive Coated Niosomes as a Sustained Oral Delivery System of Famotidine , 2017, AAPS PharmSciTech.
[10] D. Harinarayana,et al. In Vitro Intestinal Permeability Studies and Pharmacokinetic Evaluation of Famotidine Microemulsion for Oral Delivery , 2014, International scholarly research notices.
[11] Zhihong Zhu,et al. Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation. , 2014, International journal of pharmaceutics.
[12] E. Nikolsky,et al. The effect of dynasore, a blocker of dynamin-dependent endocytosis, on spontaneous quantal and non-quantal release of acetylcholine in murine neuromuscular junctions , 2014, Doklady Biological Sciences.
[13] Jie Shen,et al. Nano-amorphous spray dried powder to improve oral bioavailability of itraconazole. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[14] S Kumar,et al. Wet milling induced physical and chemical instabilities of naproxen nano-crystalline suspensions. , 2014, International journal of pharmaceutics.
[15] Y. Shimomura,et al. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability. , 2014, Toxicology.
[16] J. Patel,et al. Design and evaluation of famotidine mucoadhesive nanoparticles for aspirin induced ulcer treatment , 2013 .
[17] Hywel D Williams,et al. Strategies to Address Low Drug Solubility in Discovery and Development , 2013, Pharmacological Reviews.
[18] Imre Mäger,et al. The role of endocytosis on the uptake kinetics of luciferin-conjugated cell-penetrating peptides. , 2012, Biochimica et biophysica acta.
[19] K. Tochigi,et al. Determination and correlation of solubilities of famotidine in water + co-solvent mixed solvents , 2011 .
[20] M. Dhanaraju,et al. Evaluation of Gastric and Duodenal Antiulcer Activityof Ranitidine Formulation in Experimental Animals , 2011 .
[21] Shan Ren,et al. New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs , 2010, The Journal of pharmacy and pharmacology.
[22] F. Hirayama,et al. Evaluation of carboxymethyl-beta-cyclodextrin with acid function: improvement of chemical stability, oral bioavailability and bitter taste of famotidine. , 2010, International journal of pharmaceutics.
[23] F. Hollfelder,et al. Fluid phase endocytosis contributes to transfection of DNA by PEI-25. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[24] M. Kassem,et al. Enhancement of famotidine dissolution rate through liquisolid tablets formulation: in vitro and in vivo evaluation. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[25] S. Stainmesse,et al. Freeze-drying of nanoparticles: formulation, process and storage considerations. , 2006, Advanced drug delivery reviews.
[26] P. Malfertheiner,et al. Peptic ulcer disease , 2002, The Lancet.
[27] R. Hunt,et al. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician. , 2001, Best practice & research. Clinical gastroenterology.
[28] Mohammad A. Hassan,et al. Improvement of the in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrin , 1990 .
[29] D. T. Lyon. Efficacy and safety of famotidine in the management of benign gastric ulcers. , 1986, The American journal of medicine.
[30] Diane J Burgess,et al. Pharmaceutical Amorphous Nanoparticles. , 2017, Journal of pharmaceutical sciences.